Arshad Farid

Dr. Arshad Farid

University of Agriculture, Dera Ismail Khan
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2022 in Polymers
Verified
Journal Article
Open access
PDF file
TATariq Aziz
Tariq Aziz
AFArshad Farid
Arshad Farid
FHFazal Haq
Fazal Haq
MKMehwish Kiran
Mehwish Kiran
Asmat UllahAsmat Ullah
Asmat Ullah
SASOAD Khalil ALJAOUNI
SOAD Khalil ALJAOUNI
The latest advancements in cellulose and its derivatives are the subject of this study. We summarize the characteristics, modifications, applications, and properties of cellulose. Here, we discuss new breakthroughs in modified cellulose that allow for enhanced control. In addition to standard approaches, improvements in different techniques employed for cellulose and its derivatives are the subject of this review. The various strategies for synthetic polymers are also discussed. The recent advancements in polymer production allow for more precise control, and make it possible to make functional celluloses with better physical qualities. For sustainability and environmental preservation, the development of cellulose green processing is the most abundant renewable substance in nature. The discovery of cellulose disintegration opens up new possibilities for sustainable techniques. Based on the review of recent scientific literature, we believe that additional chemical units of cellulose solubility should be used. This evaluation will evaluate the sustainability of biomass and processing the greenness for the long term. It appears not only crucial to dissolution, but also to the greenness of any process.
1

1 September 2023 in Carbon Letters
Verified
Journal Article
Closed access
PDF file
TATariq Aziz
Tariq Aziz
FHFazal Haq
Fazal Haq
AFArshad Farid
Arshad Farid
LCLi Cheng
Li Cheng
LCLai Fatt Chuah
Lai Fatt Chuah
Pau Loke ShowPau Loke Show
Pau Loke Show

4 February 2023 in Environmental Research
Verified
Journal Article
Closed access
TATariq Aziz
Tariq Aziz
FHFazal Haq
Fazal Haq
AFArshad Farid
Arshad Farid
MKMehwish Kiran
Mehwish Kiran
SFShah Faisal
Shah Faisal
Pau Loke ShowPau Loke Show
Pau Loke Show
1

4 July 2022 in Molecules
Verified
Journal Article
Open access
PDF file
RARameesha Abid
Rameesha Abid
Shakira GhazanfarShakira Ghazanfar
Shakira Ghazanfar
AFArshad Farid
Arshad Farid
SSSamra Muhammad Sulaman
Samra Muhammad Sulaman
MIMaryam Idrees
Maryam Idrees
BABandar Fahad Alharbi
Bandar Fahad Alharbi
Plant bioactive compounds, particularly apigenin, have therapeutic potential and functional activities that aid in the prevention of infectious diseases in many mammalian bodies and promote tumor growth inhibition. Apigenin is a flavonoid with low toxicities and numerous bioactive properties due to which it has been considered as a traditional medicine for decades. Apigenin shows synergistic effects in combined treatment with sorafenib in the HepG2 human cell line (HCC) in less time and statistically reduces the viability of tumor cells, migration, gene expression and apoptosis. The combination of anti-cancerous drugs with apigenin has shown health promoting potential against various cancers. It can prevent cell mobility, maintain the cell cycle and stimulate the immune system. Apigenin also suppresses mTOR activity and raises the UVB-induced phagocytosis and reduces the cancerous cell proliferation and growth. It also has a high safety threshold, and active (anti-cancer) doses can be gained by consuming a vegetable and apigenin rich diet. Apigenin also boosted autophagosome formation, decreased cell proliferation and activated autophagy by preventing the activity of the PI3K pathway, specifically in HepG2 cells. This paper provides an updated overview of apigenin’s beneficial anti-inflammatory, antibacterial, antiviral, and anticancer effects, making it a step in the right direction for therapeutics. This study also critically analyzed the effect of apigenin on cancer cell signaling pathways including the PI3K/AKT/MTOR, JAK/STAT, NF-κB and ERK/MAPK pathways.

18 February 2022 in Gels
Verified
Journal Article
Open access
PDF file
AKAbdul Shakur Khan
Abdul Shakur Khan
KSKifayat Ullah Shah
Kifayat Ullah Shah
Mohammed Al mohainiMohammed Al mohaini
Mohammed Al mohaini
Abdulkhaliq J. AlsalmanAbdulkhaliq J. Alsalman
Abdulkhaliq J. Alsalman
MHMaitham A. Al Hawaj
Maitham A. Al Hawaj
AFArshad Farid
Arshad Farid
The currently available topical formulations of tacrolimus have minimal and variable absorption, elevated mean disposition half-life, and skin irritation effects resulting in patient noncompliance. In our study, we fabricated tacrolimus-loaded solid lipid nanoparticles (SLNs) that were converted into a gel for improved topical applications. The SLNs were prepared using a solvent evaporation method and characterized for their physicochemical properties. The particle size of the SLNs was in the range of 439 nm to 669 nm with a PDI of ≤0.4, indicating a monodispersed system. The Zeta potential of uncoated SLNs (F1–F5) ranged from −25.80 to −15.40 mV. Those values reverted to positive values for chitosan-decorated formulation (F6). The drug content and entrapment efficiency ranged between 0.86 ± 0.03 and 0.91 ± 0.03 mg/mL and 68.95 ± 0.03 and 83.68 ± 0.04%, respectively. The pH values of 5.45 to 5.53 depict their compatibility for skin application. The surface tension of the SLNs decreased with increasing surfactant concentration that could increase the adherence of the SLNs to the skin. The release of drug from gel formulations was significantly retarded in comparison to their corresponding SLN counterparts (p ≤ 0.05). Both SLNs and their corresponding gel achieved the same level of drug permeation, but the retention of the drug was significantly improved with the conversion of SLNs into their corresponding gel formulation (p ≤ 0.05) due to its higher bioadhesive properties.

21 March 2023 in Gels
Verified
Journal Article
Open access
PDF file
Niamat Ullah MianiNiamat Ullah Miani
Niamat Ullah Miani
Adnan AminAdnan Amin
Adnan Amin
AFArshad Farid
Arshad Farid
Samy SelimSamy Selim
Samy Selim
SRSheikh Abdur Rashid
Sheikh Abdur Rashid
MHMuhammad Mohtasheem Ul Hasan
Muhammad Mohtasheem Ul Hasan
Prevalence of oral infections in diabetic patients is a health challenge due to persistent hyperglycemia. However, despite great concerns, limited treatment options are available. We therefore aimed to develop nanoemulsion gel (NEG) for oral bacterial infections based on essential oils. Clove and cinnamon essential oils based nanoemulgel were prepared and characterized. Various physicochemical parameters of optimized formulation including viscosity (65311 mPa·S), spreadability (36 g·cm/s), and mucoadhesive strength 42.87 N/cm2) were within prescribed limits. The drug contents of the NEG were 94.38 ± 1.12% (cinnamaldehyde) and 92.96 ± 2.08% (clove oil). A significant concentration of clove (73.9%) and cinnamon essential oil (71.2 %) was released from a polymer matrix of the NEG till 24 h. The ex vivo goat buccal mucosa permeation profile revealed a significant (52.7–54.2%) permeation of major constituents which occurred after 24 h. When subjected to antimicrobial testing, significant inhibition was observed for several clinical strains, namely Staphylococcus aureus (19 mm), Staphylococcus epidermidis (19 mm), and Pseudomonas aeruginosa (4 mm), as well as against Bacillus chungangensis (2 mm), whereas no inhibition was detected for Bacillus paramycoides and Paenibacillus dendritiformis when NEG was utilized. Likewise promising antifungal (Candida albicans) and antiquorum sensing activities were observed. It was therefore concluded that cinnamon and clove oil-based NEG formulation presented significant antibacterial-, antifungal, and antiquorum sensing activities.